Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies
NCT00452842 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 26784
Last updated 2008-02-22
Summary
An observational safety follow up trial will be conducted to monitor the occurrence of cardiovascular events and all cause mortality in subjects who participated in selected torcetrapib/atorvastatin Phase 1, 2, and 3 clinical trials. No hypotheses will be tested.
Conditions
- Cardiovascular Disease
- Cerebrovascular Disorders
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 10 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-10-31
Countries
- United States
Study Locations
More Related Trials
-
Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone.
NCT00137462 ·Status: COMPLETED ·Phase: PHASE3
-
Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.
NCT00134238 ·Status: TERMINATED ·Phase: PHASE3
-
Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone.
NCT00136981 ·Status: COMPLETED ·Phase: PHASE3
-
Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder
NCT00134511 ·Status: COMPLETED ·Phase: PHASE3
-
Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.
NCT00145431 ·Status: TERMINATED ·Phase: PHASE3
-
A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)
NCT02099123 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular Disease
NCT00293748 ·Status: COMPLETED
-
Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients
NCT01013103 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol
NCT00138762 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol.
NCT00267254 ·Status: COMPLETED ·Phase: PHASE3
-
Study On Liprimar (Atorvastatin) In Patients With Coronary Heart Disease (CHD) And High Risk Of Cardiovascular Complications
NCT00993915 ·Status: COMPLETED
-
Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF)
NCT00252967 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Atorvastatin Versus Placebo to Reduce Cardiopulmonary Complications After Thoracic Surgery
NCT00375518 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031).
NCT00267280 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine
NCT05551624 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events
NCT00327418 ·Status: COMPLETED ·Phase: PHASE4
-
Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement
NCT05076019 ·Status: RECRUITING ·Phase: NA
-
A Formulation Screening Study of Dalcetrapib and Atorvastatin in Healthy Volunteers
NCT01363999 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Atorvastatin Treatment on Carotid Plaque.
NCT00343655 ·Status: TERMINATED ·Phase: PHASE3
-
Bioavailability Study for New Atorvastatin Formulation
NCT00844376 ·Status: COMPLETED ·Phase: PHASE4
-
Self-Assessment Method for Statin Side-effects Or Nocebo
NCT02668016 ·Status: COMPLETED ·Phase: PHASE4
-
Atorvastatin Study in Cardiovascular Disease Risk
NCT02392416 ·Status: COMPLETED
-
Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients
NCT03611010 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients
NCT01386853 ·Status: UNKNOWN ·Phase: PHASE3
-
The Multicenter Atorvastatin Plaque Stabilization (MAPS) Study
NCT01053065 ·Status: COMPLETED ·Phase: NA